CLINICAL_TRIALS
trial_result
· 2014-03-03
Clinical Trial Update: Docetaxel and Epirubicin in Advanced Gastric Cancer [Phase 2]
Summary
A Phase 2 study evaluating the combination of docetaxel and epirubicin in advanced gastric cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2014-03-03